Diagnosis of Primary Ciliary Dyskinesia.

Ciliary Motility Disorders / diagnosis Humans Nitric Oxide
Bronchiectasis Diagnosis Management Monitoring Primary ciliary dyskinesia

Journal

Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612

Informations de publication

Date de publication:
03 2022
Historique:
entrez: 3 3 2022
pubmed: 4 3 2022
medline: 6 5 2022
Statut: ppublish

Résumé

Primary ciliary dyskinesia (PCD) is a rare genetic disease leading to bronchiectasis in most patients. In addition to the lungs, PCD might affect multiple organ systems, and patients frequently have multiple clinical problems, which require multidisciplinary management. Diagnosis of PCD needs a combination of tests, many of which require expertise and expensive equipment. Measurement of nasal nitric oxide is the first test to consider when PCD is suspected. Detailed clinical history using available predictive scores in combination with information on functional and structural aspects of lung disease is important to identify which patients should be referred for further diagnostic testing.

Identifiants

DOI: 10.1016/j.ccm.2021.11.008 PMID: 35236553
pubmed: 35236553
pii: S0272-5231(21)01246-6
doi: 10.1016/j.ccm.2021.11.008
pii:
doi:

Substances chimiques

Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-140

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have no financial support to disclose. The authors are chairs of the BEAT-PCD clinical research collaboration supported by the European Respiratory Society.

Auteurs

Myrofora Goutaki (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland. Electronic address: myrofora.goutaki@ispm.unibe.ch.

Amelia Shoemark (A)

Scottish Centre for Respiratory Research, University of Dundee, Dundee, UK; PCD Diagnostic Centre, Paediatric Department, Royal Brompton Hospital, London, UK. Electronic address: https://twitter.com/Shoemelia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Ciliopathies › Troubles de la motilité ciliaire › Diagnosis of Primary Ciliary Dyskinesia.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Diagnosis of Primary Ciliary Dyskinesia.
questionsmedicales.fr › Produits chimiques inorganiques › Composés de l'oxygène › Oxydes › Oxydes d'azote › Monoxyde d'azote › Diagnosis of Primary Ciliary Dyskinesia.